scholarly journals Discovery of a highly potent and selective Bruton’s tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma

2020 ◽  
Vol 5 (1) ◽  
Author(s):  
Juan Liu ◽  
Qianmao Liang ◽  
Aoli Wang ◽  
Fengming Zou ◽  
Ziping Qi ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
B Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Hodgkin Lymphoma ◽  
Kinase Inhibitor ◽  
Bruton’S Tyrosine Kinase ◽  
Bruton's Tyrosine Kinase ◽  
Non Hodgkin Lymphoma

Bruton’s tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma

2014 ◽  
Vol 466 (2) ◽  
pp. 229-235 ◽  
Author(s):  
Iván Fernández-Vega ◽  
Luis M. Quirós ◽  
Jorge Santos-Juanes ◽  
María Pane-Foix ◽  
Teresa Marafioti
Keyword(s):  
Tyrosine Kinase ◽  
B Cell ◽  
Hodgkin Lymphoma ◽  
Bruton’S Tyrosine Kinase ◽  
Bruton's Tyrosine Kinase ◽  
Non Hodgkin Lymphoma

scholarly journals Richter transformation to Hodgkin lymphoma on Bruton’s tyrosine kinase inhibitor therapy

2018 ◽  
Vol 60 (2) ◽  
pp. 519-522
Author(s):  
Alankrita Taneja ◽  
Jade Jones ◽  
Stefania Pittaluga ◽  
Irina Maric ◽  
Mohammed Farooqui ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Hodgkin Lymphoma ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Bruton’S Tyrosine Kinase ◽  
Bruton's Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor Therapy

scholarly journals Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies

2015 ◽  
Vol 1358 (1) ◽  
pp. 82-94 ◽  
Author(s):  
Urte Gayko ◽  
Mann Fung ◽  
Fong Clow ◽  
Steven Sun ◽  
Elizabeth Faust ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
B Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Bruton’S Tyrosine Kinase ◽  
B Cell Malignancies ◽  
Bruton's Tyrosine Kinase
Sign in / Sign up

Export Citation Format

Share Document